What is a suitable taper schedule for escitalopram (Lexapro) 10 mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Escitalopram 10 mg Daily Taper Schedule

For escitalopram 10 mg daily, reduce the dose by 10% of the most recent dose every 2-4 weeks, which translates to approximately 1 mg reductions initially, with progressively smaller decrements as you approach discontinuation. 1

Specific Tapering Protocol

Initial Reduction Phase

  • Week 0-2: Continue 10 mg daily
  • Week 2-4: Reduce to 9 mg daily (10% reduction)
  • Week 4-6: Reduce to 8 mg daily (11% reduction from 9 mg)
  • Week 6-8: Reduce to 7 mg daily (12.5% reduction from 8 mg)
  • Week 8-10: Reduce to 6 mg daily (14% reduction from 7 mg)

Final Reduction Phase

  • Week 10-12: Reduce to 5 mg daily (17% reduction from 6 mg)
  • Week 12-14: Reduce to 4 mg daily (20% reduction from 5 mg)
  • Week 14-16: Reduce to 3 mg daily (25% reduction from 4 mg)
  • Week 16-18: Reduce to 2 mg daily (33% reduction from 3 mg)
  • Week 18-20: Reduce to 1 mg daily (50% reduction from 2 mg)
  • Week 20-22: Discontinue completely

Total taper duration: Approximately 20-22 weeks (5-5.5 months) 1

Critical Implementation Details

Obtaining Smaller Doses

  • Use liquid formulation if available to achieve precise dose reductions 2
  • Do NOT use alternate-day dosing (e.g., taking 10 mg every other day to achieve an "average" of 5 mg daily), as this causes severe fluctuations in receptor occupancy and dramatically increases withdrawal risk 3
  • Consider having a compounding pharmacy prepare custom capsules for doses below 5 mg 1

Monitoring and Adjustment

  • If withdrawal symptoms emerge: Return to the previous well-tolerated dose and hold for 2-4 weeks before attempting a smaller reduction (5% instead of 10%) 1, 2
  • Common withdrawal symptoms include dizziness (44%), muscle tension (44%), chills (44%), confusion (40%), and crying (28%) 4
  • Higher doses and plasma concentrations of escitalopram increase ADS risk, making gradual tapering essential 4

Slower Taper for Long-Term Users

  • If you have been on escitalopram for ≥1 year: Consider reducing by 10% per month instead of every 2-4 weeks, extending the total taper to 10-11 months 1
  • The FDA label explicitly states "a gradual reduction in the dose rather than abrupt cessation is recommended whenever possible" 2

Managing Withdrawal Symptoms

Symptomatic Treatment

  • For anxiety or irritability: Consider short-term trazodone 1
  • For sleep disturbances: Implement sleep hygiene measures and consider short-term sleep aids 1
  • For gastrointestinal symptoms: Use appropriate symptomatic treatments 1

Key Distinction

  • Do not mistake withdrawal symptoms for recurrence of your original condition 1
  • Withdrawal symptoms typically appear within days of dose reduction and last 1-3 days per step 1
  • Protracted withdrawal may occur months after complete discontinuation, manifesting as dysphoria, irritability, insomnia, or anhedonia 1

Common Pitfalls to Avoid

  • Never taper faster than 10% every 2 weeks as this dramatically increases withdrawal risk 1
  • Never abruptly discontinue escitalopram 2
  • Avoid setting arbitrary deadlines for completing the taper; prioritize tolerability over speed 1
  • Do not use alternate-day dosing as a tapering strategy, as this causes dangerous fluctuations in drug levels and receptor occupancy 3

When to Pause or Seek Help

  • Pause the taper if withdrawal symptoms become intolerable, and restart when ready 1
  • Consider cognitive-behavioral therapy during tapering to increase success rates 1
  • Seek additional help if symptoms of your original condition (depression or anxiety) worsen significantly during tapering 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.